BRKR Stock Recent News
BRKR LATEST HEADLINES
Biognosys announced its participation in the 23rd Human Proteome Organization (HUPO) World Congress from October 20 to October 24 in Dresden, Germany.
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the formation of a new division, Bruker Spatial Biology, offering the most diverse and comprehensive solutions for spatial biology. Bruker Spatial Biology brings together in operational coordination three entities: the two businesses of NanoString Technologies and Canopy Biosciences, along with its subsidiary Bruker Spatial Genomics, Inc. (formerly known as Acuity Spatial Genomics, Inc.). Bruker Spatial Biology.
At the Neuroscience 2024 conference, Bruker released its latest OptoVolt module, which seamlessly integrates with Ultima 2Pplus microscope and NeuraLight 3D SLM.
Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging
CHICAGO--(BUSINESS WIRE)---- $BRKR #BRKR--At the Neuroscience 2024 conference, Bruker Corporation (Nasdaq: BRKR) today announced the release of the OptoVolt™ module to further expand the advanced neuroscience research capabilities on Bruker's Ultima multiphoton microscope platform. OptoVolt accelerates imaging speeds to beyond 1000 frames per second for the capture of millisecond dynamics of cell-to-cell neural communication. With the emergence of fluorescent voltage indicators, researchers are excited to meas.
Bruker's robust growth potential across its Nano segment is encouraging. Yet, unfavorable currency movement is likely to pose a challenge.
MUNICH--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Dynamic Biosensors GmbH, a pioneering company known for its breakthroughs in biosensor development, which is based in Munich, Germany. This acquisition strengthens Bruker's biophysical portfolio for the analysis of molecular interactions and kinetics, offering deeper insights into both inter-molecular and molecule-single cell interactions in drug discovery or basic research. Dynamic Biosensors (DBS) de.
Investors need to pay close attention to Bruker (BRKR) stock based on the movements in the options market lately.
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Dermatology Diagnostic Devices Market (2024 Edition): Analysis by Type (Imaging Devices, Microscopes, Immunoassays, Molecular Diagnostics, Others), Application, End-user and Region: Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering. This report provides a complete analysis of the Global Dermatology Diagnostic Devices industry for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The Global Dermatology Diagnostic Devices market showcased growth at a CAGR of 10.29% during 2020-2023. The market was valued at USD 7.57 billion in 2023, and is expected to reach USD 17.65 billion in 2030.
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
BRKR's robust growth potential across its major segments is encouraging. Yet, macro woes and competitive pressure can pose challenges.